HomeSYRE • NASDAQ
Spyre Therapeutics Inc
Follow
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -101.54M | -179.79% |
Net income | -56.30M | 10.90% |
Net profit margin | — | — |
Earnings per share | -0.81 | 80.00% |
EBITDA | -61.07M | -27.88% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 603.09M | 77.76% |
Total assets | 608.48M | 77.99% |
Total liabilities | 90.68M | -42.55% |
Total equity | 517.80M | — |
Shares outstanding | 60.28M | — |
Price to book | 3.00 | — |
Return on assets | -29.75% | — |
Return on capital | -36.24% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -56.30M | 10.90% |
Cash from operations | -37.20M | -19.86% |
Cash from investing | -170.54M | -383.51% |
Cash from financing | 225.60M | 37.89% |
Net change in cash | 17.84M | -81.66% |
Free cash flow | -12.68M | 50.04% |
Previous close
$18.03
Day range
$18.08 - $18.99
Year range
$17.24 - $47.97
Market cap
1.08B USD
Avg Volume
659.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
Jan 1, 2013
Headquarters
Website
Employees
65
